These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11014130)

  • 1. [Risk groups for pancreatic and bile duct carcinomas].
    Truninger K
    Praxis (Bern 1994); 2000 Aug; 89(33):1299-304. PubMed ID: 11014130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factor for extrahepatic bile duct cancer in patients with anomalous pancreaticobiliary ductal union.
    Jung YS; Lee KJ; Kim H; Kim WH; Kim IG; Yoo BM; Kim JH; Kim MW
    Hepatogastroenterology; 2004; 51(58):946-9. PubMed ID: 15239220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gender-specific influencing factors on incidence, risk factors and outcome of carcinoma of the liver, gallbladder, extrahepatic bile duct and pancreas].
    Grundmann RT; Meyer F
    Zentralbl Chir; 2014 Apr; 139(2):184-92. PubMed ID: 24777600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in pancreaticobiliary maljunction.
    Matsumoto Y; Fujii H; Itakura J; Matsuda M; Nobukawa B; Suda K
    J Hepatobiliary Pancreat Surg; 2002; 9(1):45-54. PubMed ID: 12021897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy.
    Sheth S; Bedford A; Chopra S
    Am J Gastroenterol; 2000 Jun; 95(6):1402-10. PubMed ID: 10894571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of disease: chronic inflammation and cancer in the pancreas--a potential role for pancreatic stellate cells?
    Algül H; Treiber M; Lesina M; Schmid RM
    Nat Clin Pract Gastroenterol Hepatol; 2007 Aug; 4(8):454-62. PubMed ID: 17667994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for pancreatic cancer in high-risk individuals: a call for endoscopic ultrasound.
    Larghi A; Verna EC; Lecca PG; Costamagna G
    Clin Cancer Res; 2009 Mar; 15(6):1907-14. PubMed ID: 19276278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic inflammation and pancreatic cancer.
    McKay CJ; Glen P; McMillan DC
    Best Pract Res Clin Gastroenterol; 2008; 22(1):65-73. PubMed ID: 18206813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for biliary tract cancers.
    Khan ZR; Neugut AI; Ahsan H; Chabot JA
    Am J Gastroenterol; 1999 Jan; 94(1):149-52. PubMed ID: 9934746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer screening: state of the art.
    Gemmel C; Eickhoff A; Helmstädter L; Riemann JF
    Expert Rev Gastroenterol Hepatol; 2009 Feb; 3(1):89-96. PubMed ID: 19210116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and risk factors for pancreatic cancer.
    Lowenfels AB; Maisonneuve P
    Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):197-209. PubMed ID: 16549324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognosis and prevention in gallbladder and bile duct neoplasms].
    Hasselmann J; Hantschmann N
    Med Klin; 1973 Jul; 68(30):1000-5. PubMed ID: 4725487
    [No Abstract]   [Full Text] [Related]  

  • 14. Surveillance of pre-malignant disease of the pancreatico-biliary system.
    Friess H; Holzinger F; Liao Q; Büchler MW
    Best Pract Res Clin Gastroenterol; 2001 Apr; 15(2):285-300. PubMed ID: 11355916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer: a review of the evidence on causation.
    Hart AR; Kennedy H; Harvey I
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):275-82. PubMed ID: 18328435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Late results after operative treatment of biliopancreatic cancer].
    Schramm H; Theilig K; Schmidt S; Arnold F
    Zentralbl Chir; 2003 May; 128(5):401-5. PubMed ID: 12813639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.
    Takada T; Amano H; Yasuda H; Nimura Y; Matsushiro T; Kato H; Nagakawa T; Nakayama T;
    Cancer; 2002 Oct; 95(8):1685-95. PubMed ID: 12365016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pancreatic cancer--association with diabetes mellitus and smoking].
    Díte P; Trna J; Belobrádková J; Novotný I; Hermanová M; Vlcková P; Klímová K; Kianicka B; Lemine A; Liberda M; Geryk E
    Vnitr Lek; 2011 Feb; 57(2):159-62. PubMed ID: 21416856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precancerous lesions in the kidney.
    Van Poppel H; Nilsson S; Algaba F; Bergerheim U; Dal Cin P; Fleming S; Hellsten S; Kirkali Z; Klotz L; Lindblad P; Ljungberg B; Mulders P; Roskams T; Ross RK; Walker C; Wersäll P
    Scand J Urol Nephrol Suppl; 2000; (205):136-65. PubMed ID: 11144893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherited pancreatic cancer: improvements in our understanding of genetics and screening.
    Rulyak SJ; Brentnall TA
    Int J Biochem Cell Biol; 2004 Aug; 36(8):1386-92. PubMed ID: 15147717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.